Discontinued — last reported Q4 '25
Contract Liabilities
West Pharmaceutical Services Contract Liabilities increased by 15.8% to $62.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.1%, from $47.80M to $62.20M. Over 5 years (FY 2020 to FY 2025), Contract Liabilities shows relatively stable performance with a -1.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong future revenue visibility and customer demand, while a decrease may indicate faster fulfillment or slowing sales.
Detailed definition
This represents the obligation to transfer goods or services to a customer for which the company has already received co...
Peer comparison
Common in companies with long-term service contracts or subscription-based diagnostic models; peers with high recurring revenue often show higher balances.
contract_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | $38.10M | $61.30M | $56.80M | $65.90M | $52.00M | $68.20M | $57.50M | $56.70M | $50.00M | $53.90M | $57.90M | $52.20M | $53.80M | $53.20M | $47.80M | $46.20M | $47.30M | $53.70M | $62.20M |
| QoQ Change | — | -4.8% | +60.9% | -7.3% | +16.0% | -21.1% | +31.2% | -15.7% | -1.4% | -11.8% | +7.8% | +7.4% | -9.8% | +3.1% | -1.1% | -10.2% | -3.3% | +2.4% | +13.5% | +15.8% |
| YoY Change | — | — | — | — | +64.8% | +36.5% | +11.3% | +1.2% | -14.0% | -3.8% | -21.0% | +0.7% | -7.9% | +7.6% | -1.3% | -17.4% | -11.5% | -12.1% | +0.9% | +30.1% |
Product Breakdown
| Segment | Q4 '21 |
|---|---|
| Smart Dose | $3.90M |
| Total | $61.30M |
Contract Liabilities at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's contract liabilities?
- West Pharmaceutical Services (WST) reported contract liabilities of $62.20M in Q1 2026.
- How has West Pharmaceutical Services's contract liabilities changed year-over-year?
- West Pharmaceutical Services's contract liabilities increased by 30.1% year-over-year, from $47.80M to $62.20M.
- What is the long-term trend for West Pharmaceutical Services's contract liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's contract liabilities has grown at a -1.2% compound annual growth rate (CAGR), from $57.10M to $53.70M.
- What does contract liabilities mean?
- Money received from customers for products or services that have not yet been delivered.